Ubs Group Ag Immunocore Holdings PLC Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Ubs Group Ag holds 140,706 shares of IMCR stock, worth $4.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,706
Previous 43,719
221.84%
Holding current value
$4.08 Million
Previous $1.36 Million
205.15%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$194 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$192 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$141 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$77.4 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$63.4 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.27B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...